RBM15 and COVID-19: Considering that more mRNA genes were hypermethylated in patients with COVID-19 (Fig. 1B), we validated that the m6A writer RBM15 was highly expressed in severe COVID-19 patients, having a critical role in modulating the balance of m6A modifications and having important functions in patients with COVID-19.